Inwood Laboratories, Inc. v. Ives Laboratories, Inc.
Supreme Court of the United States
1Opinion of the CourtJustice O’Connor
This action requires us to consider the circumstances under which a manufacturer of a generic drug, designed to duplicate the appearance of a similar drug marketed by a competitor under a registered trademark, can be held vicariously liable for infringement of that trademark by pharmacists who dispense the generic drug.
I
In 1955, respondent Ives Laboratories, Inc. (Ives), received a patent on the drug cyclandelate, a vasodilator used in long-term therapy for peripheral and cerebral vascular diseases. Until its patent expired in 1972, Ives retained the exclusive right to make and sell the drug,…
2Cases cited12 opinions
- United States v. United States Gypsum Co.Supreme Court of the United States · 1948
- Zenith Radio Corp. v. Hazeltine Research, Inc.Supreme Court of the United States · 1969
- Sears, Roebuck & Co. v. Stiffel Co.Supreme Court of the United States · 1964
- Kellogg Co. v. National Biscuit Co.Supreme Court of the United States · 1938
- United States v. National Ass'n of Real Estate BoardsSupreme Court of the United States · 1950
7 more not listed; retrieve them via the Exa API.
3Cited by1,296 opinions
- Anderson v. City of Bessemer CitySupreme Court of the United States · 1985
- Cooter & Gell v. Hartmarx Corp.Supreme Court of the United States · 1990
- Bose Corp. v. Consumers Union of United States, Inc.Supreme Court of the United States · 1984
- Two Pesos, Inc. v. Taco Cabana, Inc.Supreme Court of the United States · 1992
- Gilbert v. DerwinskiUnited States Court of Appeals for Veterans Claims · 1990
1,291 more not listed; retrieve them via the Exa API.